TECO ENERGY $18.47

down -0.19


23/5/2013 02:23 PM  |  NYSE : TE  |  Industries : Utilities / Electric Power Generation, Transmission and Distribution
Last Trade: 18.47
Trade Time: May 23 2:15 PM Eastern Daylight Time
Change: -0.19 (-1.02 %)
Prev Close: 18.66
Open: 18.51
Bid: 18.47
Ask: 18.48
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives

Ticker Name Weight % Change
No ETF alternatives available.


People viewing TE also viewed: , , , ,

Competitors

Ticker Name Volume % Change
AEHI ALTERNATE ENERGY HOLDINGS 4.0K +0.67%
SSOL SUNVALLEY SOLAR 1.2M +0.20%
SEFE SEFE 93.2K +0.11%
RAMPF RAM POWER 31.6K +0.08%
BCONQ BEACON POWER 10.5K +0.07%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/8/2013 GILLETTE GORDON L President-Tampa Electric Co. -50,000 $19.03 -16.79%
5/7/2013 Brown Deirdre A Sr. VP-Corporate Strategy -14,750 $19.00 -15.38%
5/7/2013 Brown Deirdre A Sr. VP-Corporate Strategy 8,900 $16.30 10.23%
5/7/2013 Brown Deirdre A Sr. VP-Corporate Strategy 5,850 $16.21 7.21%
5/7/2013 WHITING PAUL L Director -10,634 $18.96 -80.97%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (TE), click here.
View All

TE Stock Analysis

  1. Ultratech Knocked Back, Not Knocked Out

    (UTEK,AMAT,INTC,TSM,KLAC )
    Expectations for market growth are aggressive, but Ultratech could be a major winner over the next three to five years.
  2.

    Should Investors Hang Around For More From Applied Materials?

    (AMAT,KLAC,ASML,UTEK )
    Applied Materials is showing progress, but has the 50% recovery already anticipated these improvements?

  3. Agilent Isn't Making It Easy On Investors

    (A,DHR,TER,NATI,WAT )
    Core operating performance at Agilent needs to improve
  4.

    Adasuve Deal Is Very Good For Alexza, But What About Teva?

    (ALXA,TEVA,VRX,BMY,LLY )
    Teva's partnership with Alexza looks like an expensive gamble.
  5.

    Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.

  6. Teva Still Too Cheap, But Still Too Uncertain

    (TEVA,NVS,MYL,ACT )
    Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
Free Reports
  1.

    5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
  2.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  3.

    3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
Marketplace
Trading Center